Study design: Case controlled study. Objective: To compare nutritional status and immune response in a group of spinal cord injured (SCI) patients with age and gender matched non SCI control subjects. Method: Thirty past patients of the Burwood Hospital Spinal Injuries Unit living locally were enrolled in the study. Age and gender matched non SCI control subjects were selected volunteers from hospital sta. Nutritional status was assessed by generating a Nutritional Risk Score (NRS, Appendix 1) and drawing blood for full blood count, iron studies, red blood cell folate, vitamin B12, ferritin, magnesium, and zinc. Immune status was assessed by vaccination response index (VRI) to Pneumovax 23 vaccine. Results: Full blood count, iron studies, and testing for red blood cell folate, albumin, prealbumin, vitamin B12, ferritin, magnesium and zinc were normal range for both groups. The SCI group had signi®cantly dierent median values than controls (P50.01) for haemoglobin concentration, white blood cell count, albumin, prealbumin, serum iron and % saturation. Body Mass Index (weight kg/(height cm 2 ) was 22.2 (range 15 ± 30) for the SCI group, signi®cantly less than the paired control group index of 26 (range 20 ± 32, P=0.0004). Median NRS for SCI patients was 2 (range 0 ± 6), compared to 0 (range 2 ± 4) for paired controls (P50.0001). Scores ranged from 0 to 2 for each of the ®ve NRS components for the SCI patients and 0 to 3 for the control group. There was no signi®cant dierence in the preand post-vaccination ratio for IgG, IgA, and IgM response to Pneumovax 23 vaccine. Conclusion: We have not identi®ed any nutritional or immune status abnormality in SCI patients, however the SCI patients have a lower value for certain nutritional parameters and BMI. SCI patients however are at only slight risk of nutritional problems given their NRS and their lower normal values for certain nutritional factors.
Introduction
Wound healing can be a problem in SCI patients following major surgery. While this may be due to many reasons such as the lack of pressure sensation allowing undue pressure on wounds, we were concerned about the possibility of nutritional and or immune problems following SCI that may have an eect on wound healing. Our aim was to attempt to identify and quantitate dierences in nutritional risk, nutritional proteins, and immunological response to vaccination between SCI patients and age and gender matched control subjects.
Method
Thirty past patients of the Spinal Injuries Unit, Burwood Hospital, Christchurch, New Zealand were identi®ed and enrolled in the study. The patients had no intercurrent illnesses other than the known stable SCI. Age and gender matched controls were selected from non SCI hospital sta. Permission was obtained from the SCI participants to retrieve data relating to their injury from hospital case notes. All SCI patients were otherwise well, all were injured more than one year previously and had no current problems such as chronic pressure ulcers.
Nutritional status was assessed by generating a Nutritional Risk Score (NRS, Appendix 1 1,2 and drawing blood for full blood count, iron studies, red blood cell folate, vitamin B12, ferritin, magnesium, and zinc. Immune status was assessed by vaccination response index (VRI) to Pneumovax 23 vaccine. The vaccine was administered intramuscularly. The post vaccination specimen was taken 14 days post operatively in all cases.
Informed consent was obtained from all participants prior to enrolment, drawing of blood and administration of Pneumovax. The study had ethical approval from the Canterbury Ethics Committee, Christchurch. Non parametric statistical analysis was undertaken to be Wilcoxon test (paired). Signi®cance was assumed at (P50.05).
Results
The mean age of the SCI participants was 44 years (range 22 ± 67 years), four female and 26 male, and were matched with age, gender matched controls). Twenty SCI patients had cervical injuries (C3-C7, 10 SCI patients had thoracic injuries (T11-T12).
Full blood count, iron studies, and testing for red blood cell folate, total protein, albumin, prealbumin, vitamin B12, ferritin, magnesium and zinc was performed. Median results for each group and normal ranges are presented in Table 1 . Results were not outside the normal laboratory range for either group, however the SCI group had signi®cantly dierent median values than controls (P50.01) for haemoglobin concentration, white blood cell count, albumin, prealbumin, serum iron and % saturation.
Body mass index
Median weight for SCI participants was 65.5 kg (range 50 ± 93 kg) compared to 80 kg (range 60 ± 108 kg) for the control group. Mean body mass index (weight kg/ (height cm 2 ) 22.2 (range 15 ± 30) for the SCI group, signi®cantly less than the paired control group BMI of 26 (range 20 ± 32, P=0.0004).
Nutritional risk score Median NRS for SCI patients was 2 (range 0 ± 6), compared to 0 (range 2 ± 4) for paired controls. There is a signi®cant dierence in NRS between groups: P50.0001. Scores ranged from 0 to 2 for each of the ®ve NRS components for the SCI patients and 0 to 3 for the control group. 
Immunoglobulin response
Response to Pneumovax 23 vaccine was assessed by calculating the pre/post vaccination ratio for IgG, IgA, and IgM (Table 2 ). There was no signi®cant dierence between SCI patients and the control group for any value, with all ratios lying within the normal laboratory ranges. There was no signi®cant dierence between SCI patients and controls, nor for cervical injury SCI patients compared with those with thoracic injuries.
Discussion
Our results show a signi®cant dierence in certain nutritional parameters between healthy SCI patients and age and sex matched controls. SCI patients are lighter and have lower nutritional index scores. There was a signi®cant dierence between the two groups, with SCI patients more likely to fall in the`needs monitoring' (scores 4 ± 5) group. Previous studies have suggested that indicators of nutritional function such as zinc and prealbumin have been shown to be low in SCI patients with pressure ulcers.
3,4 None of the SCI patients in our study had pressure ulcers and median blood levels of zinc and prealbumin were inside the normal range.
There is some evidence for changes in immune function following SCI, 5 including an impaired lymphocyte proliferation response in patients with complete SCI when compared with neurologically intact controls. 6 These changes may be mediated by the autonomic nervous system and be dependent upon the neurological level. 6 We found no signi®cant dierence in the ability of the SCI patients to mount an antibody response to the Pneumovax vaccine when compared to normal controls and did not demonstrate any association of strength of response with neurological level. This is consistent with responses to the trivalent 1994 ± 1995 in¯uenza vaccine reported previously. 7 Pneumococcal vaccine responses have been shown to be impaired in immunocompromised patients in a variety of clinical settings. 8 ± 10 The implication of the Pneumovax response is that in healthy SCI patients both the aerent (antigen processing and presentation) and eerent (eector) limbs of the immune system remain globally intact. This appears to include the ability to mount both T-independent responses (i.e. the IgM response to pneumococcal polysaccharides) and T-dependent (IgG and IgA) responses. However, subtle changes in immune cell function and IgG isotype secretion have not been excluded by this simple study.
Screening SCI patients for nutritional risk factors is unlikely to be useful to identify those with nutritional problems unless there is a clinical suggestion of a problem. In this situation addressing nutritional problems early may be useful in reducing the incidence of complications such as pressure ulcers. Further work could be done to investigate the relationship of impaired nutrition to immune function in SCI patients. No signi®cant dierence between the groups was seen
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